Despite caveats, exceptions, and a need for more information, researchers are enthusiastic about reslizumab, a treatment for patients with uncontrolled asthma who have exhausted other possibilities.
Newsroom
Despite caveats, exceptions, and a need for more information, researchers are enthusiastic about reslizumab, a treatment for patients with uncontrolled asthma who have exhausted other possibilities.